Financial Performance - The company expects a net profit attributable to shareholders of approximately -12 million yuan for the year 2025[3] - The expected net profit attributable to shareholders after deducting non-recurring gains and losses is approximately -41.8 million yuan for 2025[3] - In the same period last year, the net profit attributable to shareholders was -170.25 million yuan, and the net profit after deducting non-recurring gains and losses was -183.26 million yuan[5] Market and Sales Development - The company has increased its market development efforts, resulting in a year-on-year increase in product sales[7] Cost Control and Profitability - The company has strengthened cost control in raw material procurement, production, and transportation, leading to improved gross profit margins[7] - Overall profitability has improved significantly, resulting in a substantial reduction in losses for the current period[7] Earnings Forecast - There are no significant uncertainties affecting the accuracy of this earnings forecast[8] - The forecast data is preliminary and the final financial data will be disclosed in the official 2025 annual report[9]

证券代码:000623 证券简称:吉林敖东 公告编号:2026-001 吉林敖东药业集团股份有限公司 2025年度业绩预告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有虚假记载、误 导性陈述或重大遗漏。 一、本期业绩预计情况 1、业绩预告期间：2025 年 1 月 1 日至 2025 年 12 月 31 日。 2、业绩预告情况：自愿性业绩预告 （1）以区间数进行业绩预告的 单位：万元 | 项 目 | 本会计年度 | | | | 上年同期 | | --- | --- | --- | --- | --- | --- | | 归属于上市公司股 东的净利润 | 226,503.39 | | ～ | 248,222.90 | 155,139.31 | | | 比上年同期增长 | 46.00% | ～ | 60.00% | | | 扣除非经常性损益 后的净利润 | | 206,934.46 | ～ | 228,653.97 | 157,290.43 | | | 比上年同期增长 | 31.56% | ～ | 45.37% | | | 基本每股收益（元/ 股） | | 1.93 | ～ | 2.12 | 1 ...

Financial Performance Projections - The company expects a net profit in the range of -2,000 to -1,400 million CNY for 2025, compared to a loss of 3,696.46 million CNY in the previous year, indicating a significant improvement [5]. - Total profit is projected to be between 100 to 150 million CNY, a recovery from a loss of 1,640.63 million CNY in the prior year [5]. - Operating revenue is estimated to be between 33,500 to 35,000 million CNY, showing a steady increase from 31,968.68 million CNY year-over-year [5]. - The company anticipates a reduction in net loss by approximately 45% to 60% compared to the previous year [4]. - Basic earnings per share are projected to be between -0.03 to -0.02 CNY, improving from -0.06 CNY in the previous year [5]. Business Strategy - The company is focusing on three core business segments: school education services, quality education, and vocational education, to enhance its educational business layout [4]. - The establishment of new subsidiaries has led to increased investments, impacting costs in the fourth quarter [4]. Financial Data and Investor Advisory - The company has communicated with its accounting firm regarding the earnings forecast, and there are no discrepancies noted [3]. - The financial data provided is preliminary and has not been audited, with final figures to be disclosed in the official 2025 annual report [6]. - The company advises investors to make cautious decisions and be aware of investment risks due to the preliminary nature of the financial data [6].

证券代码：600158 证券简称：中体产业 公告编号：临 2026-02 中体产业集团股份有限公司 2025 年年度业绩预亏公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏，并对其内容的真实性、准确性和完整性承担个别及连带责任。 重要内容提示： 1. 本业绩预告的具体适用情形：净利润为负值。 2. 经公司财务部门初步测算，预计 2025 年年度实现归属于母公司所有者的 净利润-15,000 万元到-22,000 万元。 3.预计 2025 年年度实现归属于母公司所有者的扣除非经常性损益后的净利 润-14,000 万元到-21,000 万元。 一、本期业绩预告情况 （一）业绩预告期间 2025 年公司体育本体业务保持稳定，房地产板块受市场环境的影响，价格 持续下跌，公司对部分存在减值迹象的房地产项目进行了审慎评估，并拟计提资 产减值准备。 四、风险提示 2025 年 1 月 1 日至 2025 年 12 月 31 日 （二）业绩预告情况 1.经公司财务部门初步测算，预计 2025 年年度实现归属于母公司所有者的 净利润-15,000 万元到-22,000 万元。 2.预计 ...

Financial Performance Forecast - The company expects a net profit attributable to shareholders of the parent company for 2025 to be between 7.1 million and 10.1 million yuan, marking a turnaround from a loss in the previous year[3]. - The net profit attributable to shareholders of the parent company, excluding non-recurring gains and losses, is projected to be between -16 million and -12 million yuan for 2025[5]. - In 2024, the net profit attributable to shareholders of the parent company was -363.28 million yuan, and the net profit excluding non-recurring gains and losses was -377.99 million yuan[6]. Revenue and Profitability Strategies - The company aims to increase revenue through active market expansion and improved cost control measures, enhancing profitability[7]. - Non-recurring gains, such as government subsidies, positively impacted the net profit for the reporting period[8]. Audit and Risk Disclosure - The performance forecast is based on preliminary calculations by the finance department and has not yet been audited by registered accountants[9]. - The final data will be disclosed in the audited annual report for 2025, and investors are advised to be aware of investment risks[10].

Financial Performance - The company expects a net profit of between 1,500 and 2,200 million yuan for the year 2025, representing a decline of 58.57% to 71.75% compared to the previous year[5]. - The net profit attributable to shareholders after deducting non-recurring gains and losses is projected to be between -1,350 and -680 million yuan, compared to 2,616.03 million yuan in the previous year[5]. - The basic earnings per share is estimated to be between 0.02 and 0.03 yuan, down from 0.08 yuan in the previous year[5]. - The company anticipates non-recurring gains and losses will impact net profit attributable to shareholders by approximately 23 to 28 million yuan[6]. - The financial data presented is preliminary and has not been audited by an accounting firm, with final figures to be disclosed in the 2025 annual report[7]. Sales and Product Performance - The increase in sales volume of photovoltaic-grade germanium products is attributed to the advancement of domestic low-orbit communication satellite networking[5]. - The average selling prices and unit costs of various products, including compound semiconductor materials, have increased compared to the previous year, with unit cost growth outpacing sales price growth[6]. Expenses and Financial Management - R&D expenses have increased year-on-year as projects are progressing as planned[6]. - Financial expenses have risen due to unrecognized financing costs related to minority shareholders of a subsidiary, amounting to 25.64 million yuan[6]. - The company has seen an increase in accounts receivable due to significant sales revenue from photovoltaic-grade germanium products, leading to higher credit impairment losses[6].

证券代码：002725 证券简称：跃岭股份 公告编号：2026-004 浙江跃岭股份有限公司 2025 年度业绩预告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有虚 假记载、误导性陈述或重大遗漏。 一、本期业绩预计情况 1、业绩预告期间：2025 年 1 月 1 日至 2025 年 12 月 31 日。 2、业绩预告情况：预计净利润为正值且属于同向下降 50%以上情形 （1）以区间数进行业绩预告的 单位：万元 | 项 | 目 | 本报告期 | | | | 上年同期 | | --- | --- | --- | --- | --- | --- | --- | | 归属于上市公司股东的 | | | 1,200 | ～ | 1,800 | 4,719.45 | | 净利润 | | 比上年同期下降 | 61.86% | ～ | 74.57% | | | 扣除非经常性损益后的 | | | 270 | ～ | 405 | 482.33 | | 净利润 | | 比上年同期下降 | 16.03% | ～ | 44.02% | | | 基本每股收益（元/股） | | | 0.0469 | ～ | 0.0703 ...

证券代码：002379 证券简称：宏桥控股 公告编号：2026－018 山东宏桥铝业控股股份有限公司 2025 年度业绩预告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整， 没有虚假记载、误导性陈述或重大遗漏。 在业绩预告方面不存在分歧。 一、本期业绩预计情况 1、业绩预告期间：2025 年 1 月 1 日至 2025 年 12 月 31 日 2、业绩预告情况：预计净利润为正值且属于扭亏为盈情形 以区间数进行业绩预告： 注：山东宏桥铝业控股股份有限公司（以下简称"公司"）实施重大资产重组，通过发 行股份的方式购买山东宏拓实业有限公司（以下简称"宏拓实业"）100%股权，于 2025 年 12 月 31 日完成资产交割及股权工商变更等相关工作，宏拓实业纳入公司合并报表范围。由 于本公司与宏拓实业属于同一最终控制方，本次交易构成同一控制下的企业合并，根据企业 会计准则的规定，公司已对上年同期财务数据进行了追溯调整。上述调整后的上年同期数据 未经审计。 报告期内，宏拓实业纳入公司合并报表范围。根据《公开发行证券的公司信息披露解释 性公告第 1 号——非经常性损益》的相关规定，同一控制下企业合并产生的子公 ...

证券代码：600055 证券简称：万东医疗 公告编号：2026-009 北京万东医疗科技股份有限公司 2025 年年度业绩预告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导 性陈述或者重大遗漏，并对其内容的真实性、准确性和完整性依法承担法 律责任。 重要内容提示： 业绩预告的具体适用情形：净利润为负值。 北京万东医疗科技股份有限公司（以下简称"公司"）预计2025年 度实现归属于母公司所有者的净利润为-19,873万元到-25,683万元。预计 2025年度实现归属于母公司所有者的扣除非经常性损益后的净利润为 -21,323万元到-27,133万元。 一、本期业绩预告情况 （一）业绩预告期间 2025年1月1日至2025年12月31日。 （二）业绩预告情况 经财务部门初步测算，预计 2025 年度实现归属于母公司所有者的净利 润为-19,873 万元到-25,683 万元，与上年同期相比，将出现亏损。 预计 2025 年度实现归属于母公司所有者的扣除非经常性损益后的净利 润为-21,323 万元到-27,133 万元，与上年同期相比，将出现亏损。 二、上年同期经营业绩和财务状况 （一）公司 2 ...

Financial Projections - The estimated net profit for 2025 is projected to be between ¥66.62 million and ¥82.48 million, representing a decrease of 58.00% to 48.00% compared to the previous year[5]. - The estimated net profit after deducting non-recurring gains and losses is projected to be between ¥52.46 million and ¥66.64 million, reflecting a decline of 63.00% to 53.00% year-on-year[5]. - The company's comprehensive gross profit margin is expected to maintain around 40%[5]. - The revenue decline has been narrowing in Q3 and is expected to continue improving through the year[5]. - The financial data presented is preliminary and has not been audited by an accounting firm[4]. - The detailed financial data will be disclosed in the 2025 annual report[7]. Operational Challenges - Increased R&D expenses due to a rise in project approvals and personnel investment, alongside higher marketing costs for regional market development[6]. - The company has faced challenges such as inventory impairment provisions, decreased government subsidies, and delayed order shipments affecting net profit[6]. - The global trade environment has been pressured by U.S. tariff policy adjustments and geopolitical conflicts, impacting revenue[5]. Strategic Initiatives - The company is implementing a "four new" development strategy focusing on new businesses, products, application scenarios, and customers[6].